Smartleaf Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Smartleaf Asset Management's DGX Position: Q2 2026 in Review
Smartleaf Asset Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,120 shares worth $238K. The position accounts for 0.01% of the portfolio, ranked #762.
Smartleaf Asset Management first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Smartleaf Asset Management held 1,120 shares of Quest Diagnostics worth $238K as of Q2 2026.
- Smartleaf Asset Management left its Quest Diagnostics share count unchanged in Q2 2026.
- Quest Diagnostics made up 0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #762 holding.
- Smartleaf Asset Management first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
- 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.